A phase I/II open-label clinical trial of CPI-613 in combination with modified FOLFIRINOX in patients with locally advanced (LAPC) or borderline resectable pancreatic cancer (BRPC).
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: David L Bajor, Ho Jun Lee, J. Eva Selfridge, Amr Mohamed, Madison Conces, Melissa Amy Lumish, Sakti Chakrabarti, Amit Mahipal, Erin E. Anderson, Debbie Donohue, Sree Harsha Tirumani, Jennifer Anne Dorth, Lauren E. Henke, Lee Mayer Ocuin, John Brian Ammori, Jeffrey Hardacre, Jordan Michael Winter
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399736174